Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Duensing

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Aktuelle Urologie|January 26, 2018
[The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer]P Thelen, H Taubert, S Duensing, et al.
Der Urologe. Ausg. A|March 29, 2017
[Level IV inferior vena cava tumor thrombus : A rare diagnosis in patients with renal cell carcinoma]L Hofer, C Gasch, G Hatiboglu, et al.
Anticancer Research|June 12, 1999
Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastineN Meyer, S Duensing, G Anastassiou, et al.
Molecular Pathology : MP|January 6, 2000
Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disordersS Duensing, A Duensing, J G Meran, et al.
Oncogene|April 18, 2007
Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templatesA Duensing, Y Liu, S A Perdreau, et al.
Der Urologe. Ausg. A|August 15, 2013
[Novel preclinical models and biomarkers for prostate cancer]N Korzeniewski, M Tapia-Laliena, Y Tolstov, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Clinical and in vitro response to 13-cis-retinoic acid in interferon-alpha resistant renal cell carcinomaJ Buer, M Probst, S Duensing, et al.
Molecular Biotherapy|June 1, 1992
Biologic and therapeutic efficacy of mafosfamide in patients with metastatic renal cell carcinomaA Schomburg, T Menzel, M Hadam, et al.
Oncogene|December 26, 2001
Biological activities and molecular targets of the human papillomavirus E7 oncoproteinK Münger, J R Basile, S Duensing, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responsesU Zorn, S Duensing, F Langkopf, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Aktuelle Urologie|January 26, 2018
[The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer]P Thelen, H Taubert, S Duensing, et al.
Der Urologe. Ausg. A|March 29, 2017
[Level IV inferior vena cava tumor thrombus : A rare diagnosis in patients with renal cell carcinoma]L Hofer, C Gasch, G Hatiboglu, et al.
Anticancer Research|June 12, 1999
Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastineN Meyer, S Duensing, G Anastassiou, et al.
Molecular Pathology : MP|January 6, 2000
Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disordersS Duensing, A Duensing, J G Meran, et al.
Oncogene|April 18, 2007
Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templatesA Duensing, Y Liu, S A Perdreau, et al.
Der Urologe. Ausg. A|August 15, 2013
[Novel preclinical models and biomarkers for prostate cancer]N Korzeniewski, M Tapia-Laliena, Y Tolstov, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Clinical and in vitro response to 13-cis-retinoic acid in interferon-alpha resistant renal cell carcinomaJ Buer, M Probst, S Duensing, et al.
Molecular Biotherapy|June 1, 1992
Biologic and therapeutic efficacy of mafosfamide in patients with metastatic renal cell carcinomaA Schomburg, T Menzel, M Hadam, et al.
Oncogene|December 26, 2001
Biological activities and molecular targets of the human papillomavirus E7 oncoproteinK Münger, J R Basile, S Duensing, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Active specific immunotherapy of renal cell carcinoma: cellular and humoral immune responsesU Zorn, S Duensing, F Langkopf, et al.
Pageof 8